Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01979432
Other study ID # I11014
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date December 2013
Est. completion date December 12, 2015

Study information

Verified date January 2019
Source University Hospital, Limoges
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main objective of this study is to look for the interest forecast of the IPS as infra-clinical cardiovascular marker in the prediction of a change of the cognitive functions (MCI) at the elderly of 70 and more years old without clinical cardiovascular pathology.


Recruitment information / eligibility

Status Terminated
Enrollment 17
Est. completion date December 12, 2015
Est. primary completion date December 12, 2015
Accepts healthy volunteers No
Gender All
Age group 70 Years and older
Eligibility Inclusion Criteria:

- free-living community-dwelling men and women aged = 70 years,

- subjects free of clinical CVD related to atherosclerosis

- preserved basic activities of daily living (ADL = 6)

- without cognitive impairment (MMSE=24)

Exclusion Criteria:

- subjects with clinical history of any of the following CVD diseases : coronary artery disease (angina, myocardial infarction, coronary revascularization), cerebrovascular disease (stroke, TIA, carotid revascularization), clinical peripheral artery disease (claudication, critical limb ischemia)

- subjects with neurodegenerative, locomotor and ophtalmological diseases unable to perform the cognitive tests

- subjects unable to give written informed consent.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cardiovascular evaluation


Locations

Country Name City State
France CHU of Limoges Limoges

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Limoges

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incident "MCI" according to the following criteria (1) cognitive complaint (self-reported and/or informant) ; (2) preserved basic activities of daily living (ADL) ; (3) cognitive impairment (not normal for age and education) or decline in cognition evidenced by performance on objective cognitive tasks defined as a test performance <1.0 standard deviations below the mean of the reference group ; (4) preserved general cognitive functioning and (5) absence of dementia. one time point